CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer

E Zoni; L Chen; S Karkampouna; Z Granchi; Esther Verhoef; F La Manna; J Kelber; RCM Pelger; MD Henry; E Snaar-Jagalska; Arno van Leenders; L Beimers; P Kloen; PC Gray; G van der Pluijm; MKD Julio

doi:10.1038/onc.2017.87

CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer

E Zoni, L Chen, S Karkampouna, Z Granchi, Esther Verhoef, F La Manna, J Kelber, RCM Pelger, MD Henry, E Snaar-Jagalska, Arno van Leenders, L Beimers, P Kloen, PC Gray, G van der Pluijm, MKD Julio

Pathology

Research output: Contribution to journal › Article › Academic › peer-review

31 Citations (Scopus)

12 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	4739-4749
Number of pages	11
Journal	Oncogene
Volume	36
Issue number	33
DOIs	https://doi.org/10.1038/onc.2017.87
Publication status	Published - 2017

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/onc.2017.87

REPUB_108053_OA.pdfFinal published version, 3.76 MB

http://hdl.handle.net/1765/108053

Cite this

Zoni, E., Chen, L., Karkampouna, S., Granchi, Z., Verhoef, E., La Manna, F., Kelber, J., Pelger, RCM., Henry, MD., Snaar-Jagalska, E., van Leenders, A., Beimers, L., Kloen, P., Gray, PC., van der Pluijm, G., & Julio, MKD. (2017). CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer. Oncogene, 36(33), 4739-4749. https://doi.org/10.1038/onc.2017.87

@article{149b79bcf0ee4a96aaf6e22cac21e559,

title = "CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer",

author = "E Zoni and L Chen and S Karkampouna and Z Granchi and Esther Verhoef and {La Manna}, F and J Kelber and RCM Pelger and MD Henry and E Snaar-Jagalska and {van Leenders}, Arno and L Beimers and P Kloen and PC Gray and {van der Pluijm}, G and MKD Julio",

year = "2017",

doi = "10.1038/onc.2017.87",

language = "Undefined/Unknown",

volume = "36",

pages = "4739--4749",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Springer Nature",

number = "33",

}

Zoni, E, Chen, L, Karkampouna, S, Granchi, Z, Verhoef, E, La Manna, F, Kelber, J, Pelger, RCM, Henry, MD, Snaar-Jagalska, E, van Leenders, A, Beimers, L, Kloen, P, Gray, PC, van der Pluijm, G & Julio, MKD 2017, 'CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer', Oncogene, vol. 36, no. 33, pp. 4739-4749. https://doi.org/10.1038/onc.2017.87

TY - JOUR

T1 - CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer

AU - Zoni, E

AU - Chen, L

AU - Karkampouna, S

AU - Granchi, Z

AU - Verhoef, Esther

AU - La Manna, F

AU - Kelber, J

AU - Pelger, RCM

AU - Henry, MD

AU - Snaar-Jagalska, E

AU - van Leenders, Arno

AU - Beimers, L

AU - Kloen, P

AU - Gray, PC

AU - van der Pluijm, G

AU - Julio, MKD

PY - 2017

Y1 - 2017

U2 - 10.1038/onc.2017.87

DO - 10.1038/onc.2017.87

M3 - Article

C2 - 28394345

SN - 0950-9232

VL - 36

SP - 4739

EP - 4749

JO - Oncogene

JF - Oncogene

IS - 33

ER -